VRTX Competitors
Vertex Pharmaceuticals Incorporated
$530.76
-$22.39(-4.05%)
71
Overall
60
Value
90
Tech
63
Quality
Market Cap
$140.20B
Volume
2.37M
52W Range
$403.16 - $563.80
Target Price
$573.07
VRTX competitors: GILD, ABBV, JNJ, BMY, MRK. Vertex Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
VRTX Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| GILD Gilead Sciences, Inc. | $169.57 | $211.27B | $-1.03 | 1.92% | 80 |
| ABBV AbbVie Inc. | $286.97 | $510.41B | $13.92 | 1.81% | 70 |
| JNJ Johnson & Johnson | $267.50 | $651.32B | $11.12 | 1.97% | 70 |
| BMY Bristol-Myers Squibb Company | $62.22 | $128.82B | $6.40 | 4.05% | 78 |
| MRK Merck & Co., Inc. | $144.56 | $366.03B | $2.81 | 2.35% | 77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $530.76 | -4.0% | 2.37M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW